Myriad myPlan Lung Cancer Test Provided to Leading Physicians
Test accurately identifies which patients may need postsurgical chemotherapy.
Read MorePosted by Judy O'Rourke | Oct 29, 2013 | Cancer, Lung Cancer, Molecular Diagnostics |
Test accurately identifies which patients may need postsurgical chemotherapy.
Read MorePosted by Judy O'Rourke | Oct 21, 2013 | Cancer, Miscellaneous |
Gene N. Herbek, MD, FCAP, was recently sworn in as president of the CAP, and Richard C. Friedberg, MD, PhD, FCAP, was sworn in as president-elect.
Read MorePosted by Judy O'Rourke | Oct 21, 2013 | Cancer, Miscellaneous |
Companion diagnostic will run on QIAGEN’s efficient Rotor-Gene Q MDx platform.
Read MorePosted by Judy O'Rourke | Oct 17, 2013 | Cancer, Kidney Disease, Molecular Diagnostics, Research |
Examining 12 major types of cancer, scientists at Washington University School of Medicine in St Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body.
Read MorePosted by Judy O'Rourke | Oct 17, 2013 | Cancer, Miscellaneous, Research |
The effort will evaluate Trovagene’s proprietary, urine-based, cell-free DNA technology for the detection of certain EGFR mutations associated with lung cancer.
Read More